Merlin Capital, Inc NTLA Holdings History

Number of Shares
17,724.00
Current Holdings Value*
$487,590.00
% of Portfolio
1.45%
Total Estimate Gain
$-1.31 Mil
% of Total Estimate Gain
-72.73%

Merlin Capital, Inc's Intellia Therapeutics Inc Holding Summary

As of 2024-03-31, Merlin Capital, Inc held 17,724.00 shares of Intellia Therapeutics Inc(NTLA), totaling $487,590.00. This investment constitutes 1.45% of their stock portfolio, and Merlin Capital, Inc now holds 0.02% of the outstanding Intellia Therapeutics Inc(NTLA) stock.

The initial trade took place in 2021Q4. And since then Merlin Capital, Inc has made 7 purchases of NTLA, at an average price of $65.65, for a total of 27,351.00 shares. In addition, there have been 2 sales at an average price of $29.62 for 9,627.00 shares. Based on historical transaction data and NTLA's current price of $11.54, Merlin Capital, Inc's estimated gain on his NTLA holdings is $-1.31 Mil, reflecting a -72.73% gain to date.

Merlin Capital, Inc NTLA ($11.54) Holding Chart

Merlin Capital, Inc NTLA ($11.54) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1